Professionals’ perceptions about healthcare resources for co-occuring disorders in Spain

International Journal of Mental Health Systems

Nestor Szerman²  Miguel Casas⁴  Lara Grau-López⁴  Beatriz Mesías³  Laia Rodríguez-Cintas⁵  Ignacio Basurte-Villamor²  Carmen Barral⁴  Jose Martínez-Raga¹  Pablo Vega³  Carlos Roncero⁴ 

[1] Unidad Docente de Psiquiatría y Psicología Medica, Hospital Universitario Dr. Peset y Universidad de Valencia, & Universidad CEU-UCH, 46017 Valencia, EU, Spain;Department of Psychiatry, Hospital Universitario Gregorio Marañón, Calle Doctor Esquerdo, 46, 28007, EU, Madrid, Spain;Instituto de Adicciones. C/ Juan Esplandiú, 11-13, 28007 Madrid, EU, Spain;Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Plaça Cívica, 08193 Bellaterra (Cerdanyola del Vallès), Barcelona, EU, Spain;Department of Psychiatry, Outpatient Drug Clinic, Vall d’Hebron University Hospital - Public Health Agency, Barcelona (ASPB), CIBERSAM. Passeig de la Vall d’Hebrón, 119-129, 08035 Barcelona, EU, Spain

关键词: Drug abuse;    Mental health;    Professionals’ perception;    Resources;    Co-occurring disorders;    Dual disorders;    Dual pathology;   

Others  :  1139253
DOI  :  10.1186/1752-4458-8-35

 received in 2014-07-12, accepted in 2014-08-17,  发布年份 2014

【 摘 要 】

Background

Since provision of integrated services for patients with dual pathology or dual disorders (coexistence of an addictive disorder and other psychiatric disorders) constitutes an important challenge, this study compared the perceptions of health-care professionals with the existing, current state of specific resources for patients with dual pathology in Spain.

Methods

Epidemiological, observational, cross-sectional, multicenter study with a large, representative sample of health care professionals attending patients with dual pathology in treatment resources throughout Spain. Participants completed a specifically designed ad-hoc on-line questionnaire about their perceptions on the existence of available resources and treatment needs for patients with dual pathology. To compare professionals’ perceptions with existing available resources, the same on-line questionnaire was also completed by commissioners and managers responsible for national and regional healthcare plans on drug abuse.

Results

A total of 659 professionals, mostly psychologists (43.40%) or psychiatrists (32.93%) agreed to participate in the study. The highest degree of concordance between the perceptions of professional and the actual situation was found regarding the existence of mental health and addiction networks (either separately or unified) (74.48%), followed by specific workshops (73.08%) and sub-acute inpatient units (67.38%), specific hospitalization units (66.26%), detoxification units (63.15%) and outpatient programs (60.73%). We detected a lower degree of agreement regarding specific occupational rehabilitation centers (59.34%) day hospitals (58.93%), day centers (57.88%), outpatient intermediate resources (48.87%), psychiatric acute admission units (46.54%) and therapeutic communities (43.77%). In addition, on average, health care professionals underestimated the number of resources present in their respective communities.

Conclusions

Relevant differences exist between the perceptions of professional and existing available resources for dual pathology patients in Spain, thus supporting the need of additional efforts and strategies to establish a registry and clearly inform about available resources for patients with dual diagnosis.

【 授权许可】

   
2014 Roncero et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK: Comorbidity of mental disorders with alcohol and other drug abuse: result from the Epidemiologic Catchment Area (ECA) study. J Am Med Assoc 1990, 264:2511-2518.
• [2]Kessler RC, Nelson CB, McGonagle KA, Edlund MJ, Frank RG, Leaf PJ: The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry 1996, 66:17-31.
• [3]Weaver T, Madden P, Charles V, Stimson G, Renton A, Tyrer P, Barnes T, Bench C, Middleton H, Wright N, Paterson S, Shanahan W, Seivewright N, Ford C: Comorbidity of substance misuse and mental illness collaborative study team: comorbidity of substance misuse and mental illness in community mental health and substance misuse services. Br J Psychiatry 2003, 183:304-313.
• [4]Kessler RC: The epidemiology of dual diagnosis. Biol Psychiatry 2004, 56:730-737.
• [5]Adamson SJ, Todd FC, Sellman JD, Huriwai T, Porter J: Co-existing psychiatric disorders in a New Zealand outpatient alcohol and other drug clinical population. Aust N Z J Psychiatry 2006, 40:164-170.
• [6]Rush B, Koegl CJ: Prevalence and profile of people with co-occurring mental and substance use disorders within a comprehensive mental health system. Can J Psychiatr 2008, 53:810-821.
• [7]Pulay AJ, Stinson FS, Ruan WJ, Smith SM, Pickering RP, Dawson DA, Grant BF: The relationship of DSM-IV personality disorders to nicotine dependence- results from a national survey. Drug Alcohol Depend 2010, 108:141-145.
• [8]Swendsen J, Conway KP, Degenhardt L, Glantz M, Jin R, Merikangas KR, Sampson N, Kessler RC: Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Addiction 2010, 105:1117-1128.
• [9]Hasin D, Fenton MC, Skodol A, Krueger R, Keyes K, Geier T, Greenstein E, Blanco C, Grant B: Personality disorders and the 3-year course of alcohol, drug, and nicotine use disorders. Arch Gen Psychiatry 2011, 68:1158-1167.
• [10]Roncero C, Fuste G, Barral C, Rodríguez-Cintas L, Martínez-Luna N, Eiroa-Orosa FJ, Casas M: Therapeutic management and comorbidities in opiate-dependent patients undergoing a replacement therapy programme in Spain: the PROTEUS study. Heroin Addict Relat Clin Probl 2011, 13:5-16.
• [11]Szerman N, Lopez-Castroman J, Arias F, Morant C, Babín F, Mesías B, Basurte I, Vega P, Baca-García E: Dual diagnosis and suicide risk in a Spanish outpatient sample. Subst Use Misuse 2012, 47:383-389.
• [12]Roncero C, Daigre C, Grau-López L, Rodríguez-Cintas L, Barral C, Pérez-Pazos J, Gonzalvo B, Corominas M, Casas M: Cocaine-induced psychosis in cocaine-dependent patients. J Addict Dis 2013, 32:263-273.
• [13]Szerman N, Martínez-Raga J, Peris L, Roncero C, Basurte I, Vega P, Ruiz P, Casas M: Rethinking dual disorders/pathology. Addict Disord Their Treat 2013, 12:1-10.
• [14]Arias F, Szerman N, Vega P, Mesias B, Basurte I, Morant C, Ochoa E, Poyo F, Babin F: Abuse or dependence on cannabis and other psychiatric disorders: Madrid study on dual pathology prevalence. Actas Esp Psiquiatr 2013, 41:122-129.
• [15]Torrens M, Rossi PC, Martinez-Riera R, Martinez-Sanvisens D, Bulbena A: Psychiatric co-morbidity and substance use disorders: treatment in parallel systems or in one integrated system? Subst Use Misuse 2012, 47:1005-1014.
• [16]Roncero C, Barral C, Grau-Lopez L, Bachiller D, Szerman N, Casas M, Ruiz P: Protocols of dual diagnosis intervention in schizophrenia. Addict Disord Their Treat 2011, 10:131-154.
• [17]Farren CK, Hill KP, Weiss RD: Bipolar disorder and alcohol use disorder: a review. Curr Psychiatry Rep 2012, 14:659-666.
• [18]Grau-López L, Roncero C, Daigre C, Miquel L, Barral C, Collazos F, Casas M: Observational study on medications prescribed to dual-diagnosis outpatients. J Addict Med 2014, 8:84-89.
• [19]Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results National Comorbidity Survey. Archives of General Psychiatry 1994, 51:8-19.
• [20]Pettinati HM, O’Brien CP, Dundon WD: Current status of co-occurring mood and substance use disorders: a new therapeutic target. Am J Psychiatry 2013, 170:23-30.
• [21]Arias F, Szerman N, Vega P, Mesias B, Basurte I, Morant C, Ochoa E, Poyo F, Babin F: Madrid study on the prevalence and characteristics of outpatients with dual pathology in community mental health and substance misuse services. Adicciones 2013, 25:118-127.
• [22]Drake RE1, Xie H, McHugo GJ, Shumway M: Three-year outcomes of long-term patients with co-occurring bipolar and substance use disorders. Biol Psychiatry 2004, 56:749-756.
• [23]McGovern MP, Xie H, Segal SR, Siembab L, Drake RE: Addiction treatment services and co-occurring disorders: prevalence estimates, treatment practices, and barriers. J Subst Abuse Treat 2006, 31:267-275.
• [24]Szerman N, Vega P, Grau-López L, Barral C, Basurte-Villamor I, Mesías B, Rodríguez-Cintas L, Martínez-Raga J, Casas M, Roncero C: Need of specific resources for patients with dual pathology in Spain: results of an observational study. J Dual Diagnosis 2014, 10:84-90.
• [25]Jaen-Varas D, Ribeiro WS, Whitfield J, Mari de JJ: Mental health and psychiatric care in Bolivia: what do we know? Int J Ment Health Syst 2014, 8:18. BioMed Central Full Text
• [26]Roncero C, Gómez-Baeza S, Vázquez JM, Terán A, Szerman N, Casas M, Bobes J: Perception of Spanish professionals on therapeutic adherence of dual diagnosis patients. Actas Esp Psiquiatr 2013, 41:319-327.
• [27]Iñiguez L, Monreal P, Sanz J, Del Valle A, Fusté J: An Integrated analysis of the perceptions of health care users, professionals, and managers in catalonia [69 paragraphs]. Forum Qual Sozialforschung / Forum: Qual Social Res 2009, 10:34. Retrieved from http://nbn-resolving.de/urn:nbn:de:0114-fqs0902340 webcite
• [28]Hawkins EH: A tale of two systems: co-occurring mental health and substance abuse disorders treatment for adolescents. Annu Rev Psychol 2009, 60:197-227.
• [29]McGovern MP, Lambert-Harris C, Gotham HJ, Claus RE, Xie H: Dual diagnosis capability in mental health and addiction treatment services: an assessment of programs across multiple state systems. Adm Policy Ment Health 2014, 41:205-214.
• [30]Daigre C, Roncero C, Grau-López L, Martínez-Luna N, Prat G, Valero S, Tejedor R, Ramos-Quiroga JA, Casas M: Attention deficit hyperactivity disorder in cocaine-dependent adults: a psychiatric comorbidity analysis. Am J Addict 2013, 22:466-473.
• [31]Hofner MC, Python NV, Yersin B, Bodenmann P, Schoch M, Golay N: Local resources in management of adult victims of violence and abuse: a method of presentation and diffusion. Rev Med Suisse Romande 2002, 122:649-652.
• [32]Broekaert E, Vandevelde S, Soyez V, Yates R, Slater A: The third generation of therapeutic communities: the early development of the TC for addictions in Europe. Eur Addict Res 2006, 12:1-11.
• [33]Breton M, Pineault R, Levesque JF, Roberge D, Da Silva RB, Prud Homme A: Reforming healthcare systems on a locally integrated basis: is there a potential for increasing collaborations in primary healthcare? BMC Health Serv Res 2013, 13:262. BioMed Central Full Text